In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...

Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...

The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at ...

ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stageEarly clinical data are expected in second half of ...

Vyriad’s lentivirus vectors target T cells within a patient’s body and deliver genes coding for chimeric antigen receptors. Once the T cells decipher those genetic instructions, they are ...

internal ribosome entry siteS or 2A elements can be used to link various transgenes in bi- or multi-cistronic retroviral vectors. Lentiviral self-inactivating vectors are the retroviral vectors ...

Breakthrough in Delivering Chimeric Bait Receptors to Immune Cells Accelerates Development LONDON, UK / ACCESSWIRE / December ...

BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe ...

The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 ...